Literature DB >> 31511613

Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients.

Abhishek A Mangaonkar1, David M Swoboda2, Giacomo Coltro1, Terra L Lasho1, Paul J Novotny3, Prateek Pophali1, Ryan M Carr1, Moritz Binder1, Christy M Finke1, Naseema Gangat1, Aref Al-Kali1, Kebede H Begna1, Kaaren K Reichard4,5, Rhett P Ketterling5, Najla H Al Ali2, Pardis Vafaii6, Ling Zhang6, Eric Padron2, Chetasi Talati7, Mrinal M Patnaik8.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31511613     DOI： 10.1038/s41375-019-0574-x

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  The mutational landscape of 18 investigated genes clearly separates four subtypes of myelodysplastic/myeloproliferative neoplasms.

Authors:  Manja Meggendorfer; Sabine Jeromin; Claudia Haferlach; Wolfgang Kern; Torsten Haferlach
Journal:  Haematologica       Date:  2018-05       Impact factor: 9.941

Review 2.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

3.  An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies.

Authors:  E Padron; G Garcia-Manero; M M Patnaik; R Itzykson; T Lasho; A Nazha; R K Rampal; M E Sanchez; E Jabbour; N H Al Ali; Z Thompson; S Colla; P Fenaux; H M Kantarjian; S Killick; M A Sekeres; A F List; F Onida; R S Komrokji; A Tefferi; E Solary
Journal:  Blood Cancer J       Date:  2015-07-31       Impact factor: 11.037
  3 in total
  7 in total

Review 1.  Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.

Authors:  Mrinal M Patnaik; Terra L Lasho
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 2.  Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasms.

Authors:  Michael J Hochman; Bipin N Savani; Tania Jain
Journal:  EJHaem       Date:  2021-07-19

Review 3.  Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms.

Authors:  Laura Palomo; Pamela Acha; Francesc Solé
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

4.  Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.

Authors:  Rashmi Kanagal-Shamanna; Attilio Orazi; Robert P Hasserjian; Daniel A Arber; Kaaren Reichard; Eric D Hsi; Adam Bagg; Heesun Joyce Rogers; Julia Geyer; Faezeh Darbaniyan; Kim-Anh Do; Kyle M Devins; Olga Pozdnyakova; Tracy I George; Paola Dal Cin; Patricia T Greipp; Mark J Routbort; Keyur Patel; Guillermo Garcia-Manero; Srdan Verstovsek; L Jeffrey Medeiros; Sa A Wang; Carlos Bueso-Ramos
Journal:  Mod Pathol       Date:  2021-11-13       Impact factor: 7.842

5.  SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity.

Authors:  Abhishek A Mangaonkar; Terra L Lasho; Christy Finke; Rhett P Ketterling; Kaaren K Reichard; Kristen McCullough; Naseema Gangat; Aref Al-Kali; Kebede H Begna; William H Hogan; Mark R Litzow; Hassan Alkhateeb; Mithun Shah; Animesh Pardanani; Ayalew Tefferi; Najla H Al Ali; Chetasi Talati; David Sallman; Eric Padron; Rami Komrokji; Mrinal M Patnaik
Journal:  Haematologica       Date:  2022-05-01       Impact factor: 11.047

6.  Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53.

Authors:  Qian Wang; Hai-Ping Dai; Dan-Dan Liu; Jun-Dan Xie; Hong Yao; Zi-Xuan Ding; Ting-Ting Tao; Su-Ning Chen; Ri Zhang
Journal:  Leuk Res Rep       Date:  2020-10-30

7.  Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients.

Authors:  Abhishek A Mangaonkar; Ayalew Tefferi; Rami Komrokji; Terra L Lasho; Rhett P Ketterling; Kaaren K Reichard; Naseema Gangat; Aref Al-Kali; Kebede H Begna; Animesh Pardanani; Najla H Al Ali; Chetasi Talati; David Sallman; Eric Padron; Mrinal M Patnaik
Journal:  Blood Cancer J       Date:  2022-02-01       Impact factor: 11.037
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.